Skip to main content
CriticalFDAfda-F-1251-2023UNDECLARED ALLERGEN

Tostitos Avocado Salsa Jar Dip 15 oz, UPC 2840005597 packaged in a clear glass jar

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
100,980
Recall Date
June 16, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1251-2023.

Undeclared milk

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1251-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Frito-lay, Inc. Headquarters or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1251-2023.

Frito-Lay, Inc. Headquarters

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Frito-lay, Inc. Headquarters Recall FAQ

Frito-lay, Inc. Headquarters is the subject of a food safety report: Tostitos Avocado Salsa Jar Dip 15 oz, UPC 2840005597 packaged in a clear glass jar. The notice was published on June 16, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 100,980 units are potentially affected.